|Title||European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease|
|Date||24/11/2014 - 25/11/2014|
|Location||European Medicines Agency, London, UK|
|Summary||The Agency is organising this workshop following the public-consultation exercise on its concept paper on the need for revision of the guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias. The aim of the workshop is to make sure that, while revising its guideline, the EMA can take the most up-to-date scientific developments in understanding and treating Alzheimer’s disease into consideration, as well as the positions of experts in the field. Registration is open until 01/07/2014. Places limited.|
|Name||Language||First published||Last updated|
|Programme of European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease||(English only)||19/11/2014|
|Discussion paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias||(English only)||30/10/2014||20/11/2014|
To view the broadcast, please ensure that Adobe Flash Player is installed.
Note that you should see the live broadcast or the message ‘We are currently not broadcasting’ below, on this page. If the area below is black or in case of difficulties viewing the broadcast, please try connecting directly to our Ustream channel: European Medicines Agency or try viewing from an unrestricted connection, for example over wifi or 3G. For technical information about the required network security settings, please see this Ustream help page.
For further assistance, please consult the Ustream Help Center.
- 24 November 2014
9:30 - 17:30 UK time
- 25 November 2014
9:00 - 12:00 UK time
To watch the broadcast click on 'Multimedia' tab.
A video recording will be made available after the event.
To view use the ‘Multimedia’ tab.